MIS-C After COVID: Understanding the Syndrome in Children
In this episode of Kid’s Corner, Dr. Liz Mumper discusses MIS-C (Multisystem Inflammatory Syndrome in Children) in the United States and the incidence of this diagnosis with COVID-19. Dr. Mumper also explains if receiving COVID-19 vaccinations prevent MIS-C by breaking down this study.
People also refer to MIS-C as Pediatric Inflammatory Multisystem Syndrome temporally associated with SARS-COV2 (PIM-TS).
Common symptoms of MIS-C in babies show as a rash and/or diarrhea. In older children, the symptoms are respiratory.
MIS-C is similar to Kawasaki’s disease, although the symptoms usually resolve in contrast to Kawasaki’s disease.
Treatment for MIS-C includes:
- supportive care and observation
- maintaining volume status as dehydration worsens symptoms
- steroids
- IVIG
- Interleukin blockers
- anti-coagulation
- cardiology work-up with an EKG and cardiac echo
Make a Donation
FLCCC is dedicated to educating as many healthcare providers as possible across the globe and empowering patients with Long COVID or post vaccine injuries to take control of their own health. To help us continue this work, please consider donating to help us cover the costs of these conferences. For other donation options please visit our Donate page!
